These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 24196483)

  • 61. WT1 immunoenzyme staining using SurePath(™) processed urine cytology helps to detect kidney disease.
    Ohsaki H; Sofue T; Kawakami K; Nishijima Y; Hara T; Matsunaga T; Kushida Y; Haba R; Shigematsu Y; Irino S; Norimatsu Y
    Cytopathology; 2016 Feb; 27(1):43-9. PubMed ID: 25683486
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interest of the combined measurement of selected urinary proteins in the diagnosis approach in nephrology.
    Bastard JP; Fellahi S; Lescure FX; Capeau J; Ronco P; Plaisier E
    Ann Biol Clin (Paris); 2017 Jun; 75(3):327-333. PubMed ID: 28540855
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases.
    Szeto CC; Lai KB; Chow KM; Szeto CY; Yip TW; Woo KS; Li PK; Lai FM
    Clin Chim Acta; 2005 Nov; 361(1-2):182-90. PubMed ID: 15996647
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relationship between urinary podocytes and kidney diseases.
    Sun D; Zhao X; Meng L
    Ren Fail; 2012; 34(3):403-7. PubMed ID: 22250862
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Proteomics analysis of bladder cancer exosomes.
    Welton JL; Khanna S; Giles PJ; Brennan P; Brewis IA; Staffurth J; Mason MD; Clayton A
    Mol Cell Proteomics; 2010 Jun; 9(6):1324-38. PubMed ID: 20224111
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
    Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
    Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy.
    Moon PG; Lee JE; You S; Kim TK; Cho JH; Kim IS; Kwon TH; Kim CD; Park SH; Hwang D; Kim YL; Baek MC
    Proteomics; 2011 Jun; 11(12):2459-75. PubMed ID: 21595033
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A preliminary origin-tracking study of different densities urinary exosomes.
    Lan T; Xi X; Chu Q; Zhao L; Chen A; Lu JJ; Wang F; Zhang W
    Electrophoresis; 2018 Sep; 39(18):2316-2320. PubMed ID: 29572871
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Comprehensive analysis of urinary proteins for identification of renal disease markers].
    Nakayama A
    Rinsho Byori; 2014 Jul; 62(7):722-6. PubMed ID: 25669044
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mass spectrometry as a novel method for detection of podocyturia in pre-eclampsia.
    Garovic VD; Craici IM; Wagner SJ; White WM; Brost BC; Rose CH; Grande JP; Barnidge DR
    Nephrol Dial Transplant; 2013 Jun; 28(6):1555-61. PubMed ID: 22523117
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular and functional characterization of urine-derived podocytes from patients with Alport syndrome.
    Iampietro C; Bellucci L; Arcolino FO; Arigoni M; Alessandri L; Gomez Y; Papadimitriou E; Calogero RA; Cocchi E; Van Den Heuvel L; Levtchenko E; Bussolati B
    J Pathol; 2020 Sep; 252(1):88-100. PubMed ID: 32652570
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comprehensive analysis of low-abundance proteins in human urinary exosomes using peptide ligand library technology, peptide OFFGEL fractionation and nanoHPLC-chip-MS/MS.
    Zhang Y; Li Y; Qiu F; Qiu Z
    Electrophoresis; 2010 Dec; 31(23-24):3797-807. PubMed ID: 21082674
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Urinary Podocyte Excretion Predicts Urinary Protein Selectivity and Renal Prognosis.
    Abe M; Kaiga A; Ohira T; Ishimitsu T; Tojo A
    Int J Nephrol; 2022; 2022():2702651. PubMed ID: 35866051
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fn14 in podocytes and proteinuric kidney disease.
    Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
    Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine.
    Benito-Martin A; Ucero AC; Zubiri I; Posada-Ayala M; Fernandez-Fernandez B; Cannata-Ortiz P; Sanchez-Nino MD; Ruiz-Ortega M; Egido J; Alvarez-Llamas G; Ortiz A
    PLoS One; 2013; 8(8):e72387. PubMed ID: 24058411
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diagnostic potential of urine proteome: a broken mirror of renal diseases.
    Goligorsky MS; Addabbo F; O'Riordan E
    J Am Soc Nephrol; 2007 Aug; 18(8):2233-9. PubMed ID: 17625117
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Urinary podocalyxin as a possible novel marker of intrauterine nephrogenesis and extrauterine podocyte injury.
    Hayashi T; Tokuriki S; Okuno T; Ohta G; Igarashi A; Ohshima Y
    Pediatr Nephrol; 2017 Oct; 32(10):1891-1896. PubMed ID: 28439668
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dipping your feet in the water: podocytes in urine.
    Sir Elkhatim R; Li JY; Yong TY; Gleadle JM
    Expert Rev Mol Diagn; 2014 May; 14(4):423-37. PubMed ID: 24724555
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Activation of Galpha q-coupled signaling pathways in glomerular podocytes promotes renal injury.
    Wang L; Fields TA; Pazmino K; Dai Q; Burchette JL; Howell DN; Coffman TM; Spurney RF
    J Am Soc Nephrol; 2005 Dec; 16(12):3611-22. PubMed ID: 16267159
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rapid differentiation between glomerular and tubular proteinurias by high-performance liquid chromatography.
    Suzuki Y; Okada T; Hara M; Miura IK; Naiki S; Sakuragawa N
    Clin Nephrol; 1985 Sep; 24(3):138-41. PubMed ID: 4042443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.